Avid Bioservices Inc (CDMO)

[biopharm]

North very interesting and just trying to recap here, related to Dr Jedd Wolchok

.....Though I know JUNO failed (without Bavituximab) when many patients died and when JUNOs trial failed that was when it was announced soon after that PS Targeting going into the lab of Dr Wolchok..


This post below talked how JUNO was using some other drug to prime the cells....
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126780909

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131878924

We know the ties from Dr Wolchok to Juno after patient deaths....immediately after is when Peregrine was in with Dr Wolchok and maybe we can suspect that after patient deaths with another biotech...and bringing Dr Wolchok on board would also mean he would advise to reduce off Target toxicities / deaths, that PS Targeting is required.

July 15, 2016 - Ziopharm.

....
.....
This week, a third death was reported. The company said it is "collecting and analyzing information in order to properly and timely report it to the FDA."
The patient died of an intracranial hemorrhage, which happened after the patient had been discharged from the treatment center.
"This is an isolated case, and there have been no reported related instances of brain hemorrhage in any pervious cohort or prior studies ," the company said.

https://www.google.com/amp/www.cnbc.com/amp/2016/07/15/ziopharm-oncology-stock-falls-after-patient-death.html

What changes have Ziopharm made after patient deaths, especially with Dr Jedd Wolchok on board with Ziopharm and knowing PS Targeting reduces off Target toxicities ?

ZIOPHARM Oncology's (ZIOP) CEO Laurence Cooper on Q1 2017 Results - Earnings Call Transcript
May 1, 2017 11:27 PM•ZIOP
https://www.google.com/amp/s/seekingalpha.com/amp/article/4067662-ziopharm-oncologys-ziop-ceo-laurence-cooper-q1-2017-results-earnings-call-transcript

Dr Wolchok seems to keep in demand

Other Affiliations
Caladrius Biosciences, Inc.
Princeton University
New York University
Altor BioScience Corporation
American Society Of Clinical Oncology, Inc.
NYU Elaine A. and Kenneth G. Langone Medical Center
Cancer Research Institute, Inc.
ZIOPHARM Oncology, Inc.
Cytokines, Cellular and Molecular Therapy
Syndax Pharmaceuticals, Inc.
BeiGene, Ltd.
SELLAS Life Sciences Group AG
IFM Therapeutics, Inc.

https://www.bloomberg.com/research/stocks/private/person.asp?personId=20902847&privcapId=7924894